NIH #R01CA255323
Spectrum of clinical phenotype of the BAP1-tumor predisposition syndrome (BAP1-TPDS)
Active
- Amount
- $600K–$700K
- Period
- 2021-08-01 → 2027-07-31
- PIs
- 1
Awarded at OHIO STATE UNIVERSITY
Mohamed H. Abdel‐Rahman
Full Professor(heuristic)
Ocular Oncology and Treatments · Ophthalmology
Compare more Ophthalmology professors.
h-index51
i10-index84
Publications207
Citations42,227
Grants
3 total · 1 active
NIH #R21CA219884
Evaluation of an OCA2 enhancer variant as a modifier of the phenotype of BAP1-Tumor predisposition syndrome
- Amount
- $200K–$300K
- Period
- 2018-06-18 → 2020-05-31
- PIs
- 1
Awarded at OHIO STATE UNIVERSITY
NIH #R21CA191943
Hereditary cancer predisposition syndromes and uveal melanoma
- Amount
- $200K–$300K
- Period
- 2014-12-08 → 2016-11-30
- PIs
- 1
Awarded at OHIO STATE UNIVERSITY
Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →
Recent Public Signals
- New preprint: Clinical phenotypes of uveal melanoma in patients with germline pathogenic/likely pathogenic <i>BAP1</i> variants2026-07-01
- New paper: Impact of Multigene Panel Testing in High‐Risk Uveal Melanoma Patients (Pigment Cell & Melanoma Research)2026-07-01
- New NIH award: Spectrum of clinical phenotype of the BAP1-tumor predisposition syndrome (BAP1-TPDS)2021-08-01
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data Freshness
- Publications as of 2026-07-09
- Grants as of 2026-09-04
Data may not be current
Find elsewhere
ORCID: 0000-0002-9493-7894